| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer (NCT00681252) | Tokyo University | 2008-05-01 |
| Sorafenib Gastric Cancer Asian Phase I Study (NCT00663741) | Bayer | 2008-05-01 |
| FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer (NCT00673673) | Yale University | 2008-05-01 |
| Study of Cetuximab to Treat Gastric Cancer (NCT00699881) | Fudan University | 2008-05-01 |
| Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer (NCT00718913) | Hellenic Oncology Research Group | 2008-04-01 |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer (NCT00978549) | Cambridge University Hospitals NHS Foundation Trust | 2008-04-01 |
| Phase II Study of ABI-007 for Gastric Cancer (NCT00661167) | Taiho Pharmaceutical Co., Ltd. | 2008-04-01 |
| Proteiomic Fingerprints of Gastric Juice (NCT00834236) | Kaohsiung Veterans General Hospital. | 2008-03-01 |
| Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer (NCT00639327) | Japan Clinical Cancer Research Organization | 2008-03-01 |
| Gastric Cancer Screening Quality Improvement System Establishment (NCT02457624) | Seoul National University Hospital | 2008-03-01 |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (NCT00660205) | University of Aarhus | 2008-02-01 |
| Gastric Cancer RAD001 Study (NCT01514110) | Chinese University of Hong Kong | 2008-01-23 |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach (NCT00601705) | Case Comprehensive Cancer Center | 2008-01-05 |
| Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes (NCT01033695) | Odense University Hospital | 2008-01-01 |
| Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer (NCT00591045) | Peking University | 2008-01-01 |
| Evaluation of Four Reconstructions After Total Gastrectomy (NCT00677456) | Tang-Du Hospital | 2008-01-01 |
| Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer (NCT00601510) | Technical University of Munich | 2007-11-01 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer (NCT00568529) | Fudan University | 2007-10-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00514020) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer (NCT00737373) | Krankenhaus Nordwest | 2007-08-01 |
| Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE) (NCT00512304) | University Hospital, Rouen | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Familial Colorectal Cancer Registry in Hispanics (NCT00927680) | University of Puerto Rico | 2007-07-01 |
| Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer (NCT00595985) | Fudan University | 2007-07-01 |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer (NCT00429078) | Roger Williams Medical Center | 2007-07-01 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) (NCT00539968) | Merck Sharp & Dohme LLC | 2007-06-01 |
| A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach (NCT01132534) | National University Hospital, Singapore | 2007-06-01 |
| The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma (NCT00674167) | National University Hospital, Singapore | 2007-05-01 |
| Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract (NCT00511264) | Odense University Hospital | 2007-05-01 |
| Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC (NCT00767377) | Fudan University | 2007-05-01 |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer (NCT00524186) | Roswell Park Cancer Institute | 2007-05-01 |
| Study of Weekly DCF to Treat Advanced Gastric Cancer (NCT00568971) | Fudan University | 2007-04-01 |
| A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer (NCT00477711) | Peking University | 2007-03-01 |
| A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial (NCT00447746) | Tata Memorial Hospital | 2007-03-01 |
| Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients (NCT01704664) | Medical University of Bialystok | 2007-03-01 |
| A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. (NCT00454636) | Hoffmann-La Roche | 2007-03-01 |
| Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) (NCT00407186) | Dutch Colorectal Cancer Group | 2007-01-11 |
| CT Body Composition Enhances Survival Risk Stratification (NCT07109271) | Chang Gung Memorial Hospital | 2007-01-01 |
| The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm (NCT02682446) | Kyungpook National University Hospital | 2007-01-01 |
| Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer (NCT00415168) | Eli Lilly and Company | 2006-12-01 |
| Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors (NCT00580281) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Study of XELOX With Cetuximab in Advanced Gastric Cancer (NCT00398398) | Asan Medical Center | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer (NCT00537121) | Roswell Park Cancer Institute | 2006-11-01 |
| Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma (NCT00515411) | Memorial Sloan Kettering Cancer Center | 2006-10-23 |
| Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma (NCT00503321) | Eastern Network of Cancer Immunological Therapy, Japan | 2006-10-01 |
| Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin (NCT00397904) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma (NCT00352833) | Neovii Biotech | 2006-07-01 |
| A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer (NCT02560974) | Hoffmann-La Roche | 2006-06-01 |
| S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery (NCT00335959) | SWOG Cancer Research Network | 2006-05-01 |
| Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer (NCT00387530) | University of California, San Diego | 2006-05-01 |
| Clinical Trial for Laparoscopic D2 Gastrectomy (NCT01163812) | National Cancer Center, Korea | 2006-04-01 |
| Clinical Trial of Chemosensitivity Test (NCT00287755) | Japan Clinical Cancer Research Organization | 2006-03-01 |
| RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients (NCT01401075) | Abnoba Gmbh | 2006-03-01 |
| Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer (NCT00287768) | Japan Clinical Cancer Research Organization | 2006-03-01 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer (NCT00387348) | Massachusetts General Hospital | 2006-03-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients (NCT00738478) | Wakayama Medical University | 2006-02-01 |
| Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial (NCT00452751) | National Cancer Center, Korea | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma (NCT02002416) | Sun Yat-sen University | 2006-01-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer (NCT00533533) | Samsung Medical Center | 2006-01-01 |
| Early Onset and Familial Gastric Cancer Registry (NCT00582257) | Memorial Sloan Kettering Cancer Center | 2005-12-13 |
| Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer (NCT00275951) | National Taiwan University Hospital | 2005-12-01 |
| Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer (NCT01381913) | Kagawa University | 2005-10-01 |
| Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates (NCT00130936) | AHS Cancer Control Alberta | 2005-10-01 |
| ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer (NCT01041404) | Hoffmann-La Roche | 2005-09-01 |
| S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer (NCT00343668) | Korean Cancer Study Group | 2005-09-01 |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer (NCT00215644) | Merck KGaA, Darmstadt, Germany | 2005-08-31 |
| Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer (NCT00202969) | Taiho Pharmaceutical Co., Ltd. | 2005-07-01 |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer (NCT00130689) | Dana-Farber Cancer Institute | 2005-07-01 |
| Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer (NCT00857246) | NYU Langone Health | 2005-07-01 |
| Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery (NCT00448682) | University of Miami | 2005-06-01 |
| A Safety and Efficacy Study in Patients With Gastric Cancer (NCT00400179) | Taiho Oncology, Inc. | 2005-05-01 |
| Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00183872) | University of Southern California | 2005-04-14 |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. (NCT00209729) | Hokkaido Gastrointestinal Cancer Study Group | 2005-04-01 |
| Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer (NCT00103103) | California Cancer Consortium | 2005-03-01 |
| Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK (NCT00216034) | Hokuriku-Kinki Immunochemotherapy Study Group | 2005-03-01 |
| Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer (NCT01147991) | Cancer Research UK | 2005-03-01 |
| Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer (NCT01379482) | Uppsala University | 2005-01-01 |
| Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer (NCT00354224) | Medical University of South Carolina | 2005-01-01 |
| Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer (NCT00172627) | National Taiwan University Hospital | 2005-01-01 |
| Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation (NCT00172861) | National Taiwan University Hospital | 2005-01-01 |
| Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer (NCT00183898) | University of Southern California | 2004-12-28 |
| Postoperative Enteral Immunonutrition in Gastric Cancer (NCT02647476) | Jagiellonian University | 2004-11-01 |
| Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial (NCT00278863) | Asan Medical Center | 2004-11-01 |
| Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication (NCT01678027) | National Cancer Center, Korea | 2004-11-01 |
| Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma (NCT00323830) | Samsung Medical Center | 2004-10-01 |
| Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer (NCT00439608) | Brown University | 2004-10-01 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer (NCT00486356) | University of Nebraska | 2004-10-01 |
| Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00217581) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer (NCT00134095) | Fukushima Medical University Hospital | 2004-09-01 |
| Quality of Life Among Long-Term Survivors of Resected Gastric Cancer (NCT00598546) | Memorial Sloan Kettering Cancer Center | 2004-09-01 |
| Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer (NCT00629863) | North Wales Organisation for Randomised Trials in Health | 2004-09-01 |
| Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (NCT00210184) | Institut Bergonié | 2004-07-21 |
| Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients (NCT00447967) | Hellenic Oncology Research Group | 2004-07-01 |